The largest community of pharma leaders

Great Bay Bio was Founded to Build a Platform for CMC Technology and Pre-Clinical Research and Development of Big Data Services for Innovative Drugs, Dr. Michael Chan as CEO

HONG KONG–(BUSINESS WIRE)–Great Bay Bio, a leading biotechnology company dedicated to innovative drug CMC (Chemistry Manufacturing and Controls) and pre-clinical development of big data service platform, announced its formal establishment in Hong Kong today and the Chairman, Mr. Kingsley Leung is pleased to appoint Mr. Michael Chan as CEO and co-founder of the company on behalf of the board. Dr. Michael Chan has officially assumed his duties on May 20. He will formulate a sustainable developm….

 

 

http://www.businesswire.com/news/home/20190602005131/en/Great-Bay-Bio-Founded-Build-Platform-CMC

Recent Articles

TAGRISSO Reduced the Risk of Disease Recurrence in the Brain by 82% in the Adjuvant Treatment of Early-Stage EGFR-Mutated Lung Cancer

WILMINGTON, Del.--(BUSINESS WIRE)--Results from a prespecified exploratory analysis of the positive...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.